| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000787269 |
| P356 | DOI | 10.1038/SREP38498 |
| P932 | PMC publication ID | 5143979 |
| P698 | PubMed publication ID | 27929108 |
| P50 | author | Jin-Hoi Kim | Q56761554 |
| Abu Musa Md Talimur Reza | Q87925151 | ||
| Hideyo Yasuda | Q114390207 | ||
| P2093 | author name string | Yun-Jung Choi | |
| P2860 | cites work | miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway. | Q53240276 |
| Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma. | Q54199230 | ||
| KEGG: kyoto encyclopedia of genes and genomes | Q24515297 | ||
| Mesenchymal stem cell secretome and regenerative therapy after cancer | Q27007499 | ||
| MicroRNA biogenesis pathways in cancer | Q27013841 | ||
| Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma | Q27324064 | ||
| The role of let-7 in cell differentiation and cancer | Q28259549 | ||
| MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells | Q28263458 | ||
| Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance | Q28535423 | ||
| MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. | Q33932172 | ||
| hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3. | Q34031000 | ||
| miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression | Q34248579 | ||
| MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression. | Q34294469 | ||
| miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets | Q34369490 | ||
| MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling | Q34619254 | ||
| MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1. | Q34687078 | ||
| MicroRNA-139-3p indicates a poor prognosis of colon cancer | Q34733024 | ||
| Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation | Q35009403 | ||
| miR-127 regulates cell proliferation and senescence by targeting BCL6. | Q35055094 | ||
| miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer | Q35095838 | ||
| Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R | Q35103309 | ||
| Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma | Q35203269 | ||
| Retracted: MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer | Q35227870 | ||
| Signaling by exosomal microRNAs in cancer. | Q35344075 | ||
| Exosome and exosomal microRNA: trafficking, sorting, and function | Q35543884 | ||
| Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine | Q35755274 | ||
| Embryonic-maternal cross-talk via exosomes: potential implications | Q35846774 | ||
| miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer | Q35921263 | ||
| Tumour exosome integrins determine organotropic metastasis. | Q36677568 | ||
| Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma | Q36718761 | ||
| MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells | Q37445780 | ||
| miR-181b as a key regulator of the oncogenic process and its clinical implications in cancer (Review). | Q37565608 | ||
| Clinical relevance of circulating cell-free microRNAs in cancer | Q38184908 | ||
| Mesenchymal stem cells and cancer: friends or enemies? | Q38186855 | ||
| Diverse roles of miR-29 in cancer (review). | Q38191459 | ||
| MicroRNA-100 functions as a tumor suppressor by inhibiting Lgr5 expression in colon cancer cells | Q38302387 | ||
| MicroRNA-218 increases cellular sensitivity to Rapamycin via targeting Rictor in cervical cancer | Q38882913 | ||
| MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2. | Q38882970 | ||
| miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression. | Q38889145 | ||
| Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes | Q38895164 | ||
| Regulation of growth of human bladder cancer by miR-192. | Q38922382 | ||
| MicroRNA-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of Sox4. | Q38922802 | ||
| MicroRNA-103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c-Myb | Q38926425 | ||
| Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer | Q38931603 | ||
| MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19. | Q38932189 | ||
| MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating | Q38942653 | ||
| miR-143 inhibits cell proliferation by targeting autophagy-related 2B in non-small cell lung cancer H1299 cells | Q38947196 | ||
| Deregulation of miR-128 in ovarian cancer promotes cisplatin resistance | Q38953995 | ||
| MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma | Q38955494 | ||
| miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma | Q38955621 | ||
| MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells | Q38988557 | ||
| microRNAs 424 and 503 are mediators of the anti-proliferative and anti-invasive action of the thyroid hormone receptor beta | Q38998609 | ||
| MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway. | Q39029964 | ||
| Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer | Q39035575 | ||
| KGF and BMP-6 intervene in cellular reprogramming and in mesenchymal-epithelial transition (MET) of 3T3L1 mouse adipose cells | Q39078487 | ||
| miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC). | Q39093511 | ||
| Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model | Q39132892 | ||
| miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression | Q39180392 | ||
| Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells | Q39258781 | ||
| Interaction between adipose tissue stromal cells and gastric cancer cells in vitro | Q39579605 | ||
| Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model | Q39998770 | ||
| Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract | Q40285574 | ||
| Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK. | Q40560214 | ||
| Decreased expression of microRNA-107 predicts poorer prognosis in glioma | Q41570375 | ||
| miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1. | Q41759723 | ||
| miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer | Q42051478 | ||
| Keratinocyte growth factor and thiazolidinediones and linolenic acid differentiate characterized mammary fat pad adipose stem cells isolated from prepubertal Korean black goat to epithelial and adipogenic lineage | Q45328207 | ||
| MicroRNA-338-3p inhibits colorectal carcinoma cell invasion and migration by targeting smoothened. | Q45929700 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 38498 | |
| P577 | publication date | 2016-12-08 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells | |
| P478 | volume | 6 |
| Q91645137 | A Snapshot of The Tumor Microenvironment in Colorectal Cancer: The Liquid Biopsy |
| Q47105314 | A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies. |
| Q91658925 | Adipose-Derived Stem Cells in Cancer Progression: New Perspectives and Opportunities |
| Q89657824 | Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments |
| Q59152443 | Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes |
| Q92816292 | Concise Review: Adipose-Derived Stem Cells (ASCs) and Adipocyte-Secreted Exosomal microRNA (A-SE-miR) Modulate Cancer Growth and proMote Wound Repair |
| Q64899599 | Emerging Function and Clinical Values of Exosomal MicroRNAs in Cancer. |
| Q58804582 | Engineering exosomes: a new direction for anticancer treatment |
| Q64998142 | Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled. |
| Q47101400 | Exosomal microRNA remodels the tumor microenvironment |
| Q89897841 | Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2 |
| Q99563010 | Extracellular Vesicles in the Tumour Microenvironment: Eclectic Supervisors |
| Q45338563 | Extracellular vesicle-mediated transport of non-coding RNAs between stem cells and cancer cells: implications in tumor progression and therapeutic resistance. |
| Q47148289 | Extracellular vesicles as regulators of tumor fate: crosstalk among cancer stem cells, tumor cells and mesenchymal stem cells. |
| Q64096242 | Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Endometrial Cancer Cell Proliferation and Migration through Delivery of Exogenous miR-302a |
| Q37718845 | Human omental adipose-derived mesenchymal stem cell-conditioned medium alters the proteomic profile of epithelial ovarian cancer cell lines in vitro |
| Q57267992 | Infection of Epstein⁻Barr Virus in Type III Latency Modulates Biogenesis of Exosomes and the Expression Profile of Exosomal miRNAs in the Burkitt Lymphoma Mutu Cell Lines |
| Q58704491 | Interaction of hematopoietic CD34+ CD45+ stem cells and cancer cells stimulated by TGF‑β1 in a model of glioblastoma in vitro |
| Q98466194 | Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment |
| Q90152299 | MSC-Derived Exosomes-Based Therapy for Peripheral Nerve Injury: A Novel Therapeutic Strategy |
| Q50215302 | Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma |
| Q90056972 | Mesenchymal Stem Cells Beyond Regenerative Medicine |
| Q92798740 | Mesenchymal Stem Cells and Cancer: Clinical Challenges and Opportunities |
| Q90412540 | Mesenchymal stem cells from different sources and their derived exosomes: A pre-clinical perspective |
| Q64067018 | MicroRNA Shuttle from Cell-To-Cell by Exosomes and Its Impact in Cancer |
| Q38615248 | MicroRNA-7641 is a regulator of ribosomal proteins and a promising targeting factor to improve the efficacy of cancer therapy. |
| Q47191996 | Microarray profiling of miRNA and mRNA expression in Rag2 knockout and wild-type mouse spleens. |
| Q55509415 | Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review). |
| Q89293897 | Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology |
| Q92570648 | Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target |
| Q57167334 | Roles of microRNAs in mammalian reproduction: from the commitment of germ cells to peri-implantation embryos |
| Q92637198 | Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells |
| Q98885228 | The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer Cells |
| Q52581537 | The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications. |
| Q47134018 | Tumor-derived exosomes in ovarian cancer - liquid biopsies for early detection and real-time monitoring of cancer progression |
| Q50578324 | Tumour-adipose tissue crosstalk: fuelling tumour metastasis by extracellular vesicles. |
| Q53489250 | Vesiculated Long Non-Coding RNAs: Offshore Packages Deciphering Trans-Regulation between Cells, Cancer Progression and Resistance to Therapies. |
| Q90408448 | miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma |
Search more.